Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0H0ZU
|
|||
Former ID |
DIB015803
|
|||
Drug Name |
MP-435
|
|||
Synonyms |
C5a antagonist (rheumatoid arthritis), Mitsubishi Tanabe
Click to Show/Hide
|
|||
Indication | Rheumatoid arthritis [ICD-11: FA20] | Discontinued in Phase 2 | [1] | |
Company |
Mitsubishi Tanabe Pharma Corp
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Complement C5 (CO5) | Target Info | Antagonist | [2] |
KEGG Pathway | Complement and coagulation cascades | |||
Prion diseases | ||||
Pertussis | ||||
Staphylococcus aureus infection | ||||
Herpes simplex infection | ||||
Systemic lupus erythematosus | ||||
Reactome | Activation of C3 and C5 | |||
Peptide ligand-binding receptors | ||||
G alpha (i) signalling events | ||||
Regulation of Complement cascade | ||||
WikiPathways | Complement Activation, Classical Pathway | |||
Human Complement System | ||||
Spinal Cord Injury | ||||
Allograft Rejection | ||||
GPCR ligand binding | ||||
GPCR downstream signaling | ||||
Complement cascade |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027730) | |||
REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027730) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.